Announcements Trials
Browse Landscape

Phase

Phase 2/3 3

Status

Unknown 3Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 36Lymphoid 15Myeloid 9Other neoplasm 3Genitourinary 2Gastrointestinal 2Tumor-Agnostic 1Other solid neoplasm 1Classical hematology 1Breast 1

Conditions

TP53 1Primary Malignant Neoplasm of Ovary 1Allogeneic Hematopoietic Stem Cell Transplantation 1

Interventions

Cyclophosphamide 5Decitabine 3Carboplatin 3Busulfan 3Radiotherapy 2Endoscopy 2Chemoradiotherapy 2Capecitabine 2sintilimab 1sargramostim 1liposomal doxorubicin 1fludarabine phosphate 1exemestane 1camrelizumab 1alethine 1Watchful Waiting 1Vincristine 1Ultrasonography, Doppler 1Rifampin 1Proton Therapy 1Polymerase Chain Reaction 1Patient Reported Outcome Measures 1Papanicolaou Test 1Paclitaxel 1Observation 1Mycophenolic Acid 1Methylation 1Mass Spectrometry 1Liver Transplantation 1Laparoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Decitabine × Other neoplasm × Clear all
NCT04123392 2019-10-10

Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCT

Nanfang Hospital, Southern Medical University

Phase 2/3 Unknown
196 enrolled
Other neoplasm

TP53

NCT04098653 2019-09-23

Decitabine + BUCY vs BUCY Conditioning Regimen for Myeloid Tumors Undergoing Allo-HSCT

Nanfang Hospital, Southern Medical University

Phase 2/3 Unknown
196 enrolled
Other neoplasm

Allogeneic Hematopoietic Stem Cell Transplantation

NCT02159820 2014-06-10

DAC and CT

Chinese PLA General Hospital

Phase 2/3 Unknown
500 enrolled
Other neoplasm

Primary Malignant Neoplasm of Ovary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡